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*(E A Walker and S Rauz share the role of senior author)AbstractGlucocorticoids (GCs) have a profound effect on adipose
biology increasing tissue mass causing central obesity. The pre-
receptor regulation of GCs by 11b-hydroxysteroid dehydro-
genase type 1 (11b-HSD1) that activates cortisol from cortisone
has been postulated as a fundamental mechanismunderlying the
metabolic syndrome mediating adipocyte hyperplasia and
hypertrophy in the omental (OM) depot. Orbital adipose tissue
(OF) is the site of intense inflammation and tissue remodelling in
several orbital inflammatory disease states. In this study, we
describe features of the GC metabolic pathways in normal
human OF depot and compare it with subcutaneous (SC) and
OM depots. Using an automated histological characterisation
technique, OF adipocytes were found to be significantly smaller
(parameters: area, maximumdiameter and perimeter) thanOM
and SC adipocytes (P!0.001). Although immunohistochem-
ical analyses demonstrated resident CD68C cells in all threeThis is an Open Access article distributed under the terms of the Society for Endo
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0022–0795/07/0192–279 q 2007 Society for Endocrinology Printed in Greatwhole tissue adipose depots, OF CD68 mRNA and protein
expression exceeded that of OM and SC (mRNA, P!0.05;
protein, P!0.001). In addition, there was higher expression of
glucocorticoid receptor (GR)amRNA in the OF whole tissue
depot (P!0.05). Conversely, 11b-HSD1 mRNA together
with the markers of late adipocyte differentiation (FABP4 and
G3PDH)were significantly lower inOF.Primary culturesofOF
preadipocytes demonstrated predominant 11b-HSD1 oxo-
reductase activity with minimal dehydrogenase activity. Orbital
adipocytes are smaller, less differentiated, and express low levels
of 11b-HSD1 but abundant GRa compared with SC andOM.
OF harbours a large CD68C population. These characteristics
define an orbital microenvironment that has the potential to
respond to sight-threatening orbital inflammatory disease.
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Adipose tissue is a highly active endocrine organ regulated not
only by a range of external factors, such as the autonomic
nervous system and circulating hormones, but also has the
ability to modulate its own metabolic activity. One important
group of regulating factors are the adrenocorticosteroids. Of
these, glucocorticoids (GCs) have a profound effect on
adipose biology increasing tissue mass giving rise to obesity in
conditions such as Cushing’s disease or following the use of
exogenous glucocorticoids. Their role in simple obesity is,
however, controversial. Regulation of adipose tissue mass
involves integration of a variety of complex mechanisms,
including the enzyme 11b-hydroxysteroid dehydrogenase
type 1 (11b-HSD1). 11b-HSD1 is an NADPH-dependent
short-chain alcohol dehydrogenase, localised in the lumen of
the endoplasmic reticulum, that interconverts active andinactive GCs (Tomlinson et al. 2004). Although it has
bidirectional capacity, in vivo it functions as an oxo-reductase
activating cortisol from cortisone due to the provision of a
cofactor, NADPH, by a second regulatory enzyme, hexose-
6-phosphate dehydrogenase (H6PDH), thereby mediating
glucocorticoid receptor (GR) responses (Draper et al. 2003,
Bujalska et al. 2005). 11b-HSD1 is involved in a number of
disease processes, including insulin resistance (Kotelevtsev
et al. 1997), osteoporosis (Cooper et al. 2000, Tomlinson et al.
2000), glaucoma (Rauz et al. 2003), ocular surface renewal
(Onyimba et al. 2006), inflammation (Thieringer et al. 2001,
Zhang et al. 2005) and the metabolic syndrome – a cluster of
cardiovascular risk factors, including hypertension, obesity,
hyperlipidaemia and insulin resistance (Masuzaki et al. 2003).
11b-HSD1 is highly expressed in human omental (OM)
and subcutaneous (SC) tissue, although expression and
activity are higher in OM preadipocytes, the fibroblast-likecrinology’s Re-use Licence which permits unrestricted non-commercial use,
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I J BUJALSKA and others . 11b-HSD1 and orbital fat280precursors of mature adipocytes, when compared with SC
adipose tissue (Bujalska et al. 1997, 1999). The enzyme is
induced upon adipocyte differentiation in human adipose
tissue cultures (preadipocytes to adipocytes) and is thought to
be related to a ‘switch’ in enzyme set point from
dehydrogenase (preadipocytes) to oxo-reductase (adipocytes)
without any significant change in 11b-HSD1 mRNA levels
(Bujalska et al. 2002). This observation is explained by the
induction of H6PDH across differentiation (Bujalska et al.
2005). With the known effect of glucocorticoids on adipose
tissue function and distribution, it has been postulated that the
enhanced conversion of cortisone to cortisol within omental
adipose tissue plays an important role in the pathogenesis of
central obesity (Bujalska et al. 2002, Tomlinson et al. 2002).
Cortisol generation after exogenous introduction of
cortisone, however, is reduced with increasing body mass
index (BMI), and a reduction in activity and expression of
11b-HSD1 in OM preadipocytes derived from samples taken
from obese volunteers, is seen. These data suggest that hepatic
11b-HSD1 protects against the metabolic effects of simple
obesity (Tomlinson et al. 2004). Nevertheless, central obesity
is a characteristic feature of mice overexpressing 11b-HSD1
within adipocytes (Masuzaki et al. 2001). The mechanisms
underlying obesity are complex, but recent findings suggest a
further role for chronic inflammation that may activate
adipose tissue. Increased accumulation of CD68C macro-
phages is seen in SC adipose depots in patients with high BMI
and obese phenotypes, and increased expression of monocyte
chemoattractant protein (MCP)-1, macrophage inflam-
matory protein (MIP)-1a and MAC-1 is evident in rodent
white adipose tissue after diet-induced obesity (Weisberg et al.
2003, Wellen & Hotamisligil 2003, Xu et al. 2003).
Orbital fat (OF) represents a highly specialised adipose
tissue depot that occupies the space behind the eyeball
(known as the orbit). OF fills most of the orbital cavity, and
surrounds the globe, extraocular muscles, nerves and vessels
providing support to these delicate structures and protecting
against sight-threatening mechanical and inflammatory
trauma (Wolfram-Gabel & Kahn 2002). Two types of orbital
adipose tissue have been defined: anterior OF consisting
chiefly of small adipocytes that are separated by thick
conjunctival septa providing support to intraorbital structures,
and posterior OF consisting of larger adipocytes separated by
thin conjunctival septa enabling structural movements within
the orbit (Bremond-Gignac et al. 2004). Over 60% of orbital
disorders are inflammatory in origin (Rootman 2002). OF is
the site for intense inflammation in several disease states of the
orbit including local conditions, such as orbital cellulitis,
orbital myositis, idiopathic orbital inflammatory disease, as
well as systemic metabolic disorders (thyroid-associated
ophthalmopathy) and generalised vasculitides (Wegener’s
granulomatosis). Orbital fibroblasts and other resident orbital
cells (macrophages and dendritic cells) are known to
participate in the initiation and perpetuation of many of
these disease processes secreting mediators that are crucial to
orchestrating orbital immune and inflammatory responses andJournal of Endocrinology (2007) 192, 279–288tissue matrix remodelling (Burnstine et al. 1998, Heufelder
2000). OF, like SC and OM depots, expresses GR (Heufelder
et al. 1992, Burnstine et al. 1998, Muhlberg et al. 2000).
Exogenous GCs are known to modulate the autocrine and
paracrine interactions between OF and resident or infiltrating
inflammatory cells (lymphocytes and macrophages), leading
to the secretion of chemokines and cytokines (Burnstine et al.
1998, Valyasevi et al. 2001, Kumar & Bahn 2003, Chen et al.
2005), mediating OF proliferation (Heufelder & Bahn 1994)
and production of matrix proteins (Kaback & Smith 1999,
Han & Smith 2005). To date, no studies have characterised
the role of 11b-HSD1 and the pre-receptor regulation of
endogenous glucocorticoids in OF. In this study, we describe
features of the GC metabolic pathways in normal human OF
depot and compare it with SC and OM depots.Materials and Methods
Collection of human adipose tissue
PairedOMandSC fatwas obtained from50non-obese (BMI!
25 kg/m2) patients undergoing elective abdominal surgery for
non-malignant conditions. Surgically acquired normal orbital
adipose tissue specimens (avoiding the anterior and nasal orbital
adipose tissue) were obtained from 40 non-obese (BMI!
25 kg/m2) patients undergoing orbital or eyelid reconstructive
procedures carried out at a regional tertiary referral centre
(Birmingham and Midland Eye Centre, Birmingham, UK).
Patients with orbital tumours, those on exogenous corticoster-
oids, or with underlying endocrine disease were excluded from
the study. Each fat specimen was fixed in formalin, stored in
RNAlater atK20 8C for RNA extraction or placed in a sterile
universal container for immediate processing where sufficient
starting tissue was available.Characterisation of whole tissue adipocyte morphology
Formalin fixed paraffin embedded 5 mm sections of OF
(nZ17), SC (nZ8) and OM tissue (nZ8) were stained with
haematoxylin and eosin and photographed in triplicate using
an Olympus-BH-2-RFC microscope (Olympus UK Ltd,
Southall, Middx, UK) and MicroFireTM-S99808 camera
(Indigo Scientific, Baldock, Herts, UK). The images were
processed using the green channel to enhance edge
prominence using Image-Pro Plus (v4.0, Media Cybernetics,
Silver Spring, MD, USA). Software parameters were
optimised in order to identify the visual edge of the cell
membrane and generate an outline of the cell profiles for
analysis. The scaling factor was calculated by photographing a
micro-grid counting area of 500!584 mm capturing a
minimum of 100 cells (the exact number varying according
to the size of the adipocytes). Images were taken in triplicate
for each specimen, i.e. approximately 300 adipocytes were
evaluated for each histological section examined. The
following descriptive variables were measured: cell diameter,www.endocrinology-journals.org
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centroid; roundness, ((perimeter)2/4parea); radius ratio,
largest radius/smallest radius; feret length, calliper longest
length; cell area (mm2); heterogeneity, fraction of pixels that
deviate more than 10% from average intensity and margina-
tion, relative distribution of object intensity between centre
and margin (larger value represents brighter centre and 0.33
represents homogeneity).Immunohistochemistry
Immunohistochemical analyses were performed on 5 mm
sections OF, SC and OM tissues mounted on charged slides.
CD68 immunohistochemistry Dewaxed and rehy-
drated slides of OF, SC and OM sections were blocked
with hydrogen peroxide for 15 min before antigen
retrieval using Tris/EDTA tris-buffered saline (TBS)
buffer at pH 7.8 and a microwave at full power
(900 W) for 15 min. All sections were allowed to cool
to room temperature before being rinsed in water. All
incubations and washes were performed using the
Shandon sequenza. A biotin block was performed on
the sections for 10 min using the Zymed avidin/biotin
blocking kit (Invitrogen Ltd) before incubating with
primary antibody (CD68 clone PG-M1 (Dako, Carpin-
teria, CA, USA) 1:100 dilution) in 10% (v/v) normal
swine serum in TBS buffer for 60 min. Negative control
sections were incubated in TBS buffer without primary
antibody. The positive control sections used were human
tonsil tissue. The sections were then washed in TBS
buffer before incubating in Link reagent (Dakocytomation
(yellow)) for 10 min. The sections were then rinsed again
in TBS buffer (pH 7.8), incubated with streptavidin
reagent from Dakocytomation (red) for 10 min, rinsed in
TBS buffer (pH 7.8) before incubating with CheMate
liquid 3,3 0-diaminobenzidine (DAB; TBS buffer, 1:50) for
approximately 10 min. Finally, sections were counter-
stained with Meyer’s haematoxylin for 45 s and processed
100% (v/v) ethanol and xylene. CD68 positive cells were
counted in triplicate by masked observers in three
identical fields of view per slide for each adipose depot.11b-HSD immunohistochemistry Immunoperoxidase
studies were performed on OF sections using antisera raised in
sheep against human 11b-HSD1 (amino acid residues 18–33)
and 11b-HSD2 (amino acid residues 137–160 and 334–358;
The Binding Site, Birmingham, UK). Antibody dilutions
were in the ratio of 1:100 for 11b-HSD1 and 1:100 for 11b-
HSD2. Control sections included the omission of primary
antibody and use of antibody pre-treated with the immunis-
ing peptides. Secondary antibodies comprised donkey anti-
sheep peroxidase conjugate (1:100; Binding Site). Sections
were visualised with the peroxidase substrate DAB. Humanwww.endocrinology-journals.orgliver and kidney sections were used as positive control tissues
for 11b-HSD1 and 11b-HSD2 respectively.Orbital preadipocyte isolation and primary cultures
Orbital (nZ12), SC (nZ34) and OM (nZ34) preadipocytes
were isolated using methodology previously reported (Bujalska
et al. 2002). The OF protocol was adapted to maximise yield
from the small sample size. Briefly, orbital adipose tissue biopsies
were washed in PBS containing 50 000 U/l penicillin and
50 000 mg/l streptomycin (Life Technologies, Inc.). The tissue
was minced with sterile scissors in a Class II culture hood and
digested with collagenase class I (2 mg/ml; Worthington
Biochemical Corp., Reading, UK) in 1! Hanks’ Balanced
Salt Solution (Gibco Invitrogen Corporation) for 45 min at
37 8C. Samples were centrifuged at 500 g for 1 min, and the
supernatant containing connective tissue debris, collagenase and
lipid was removed leaving a pellet containing preadipocytes.
The cellular pelletwaswashedwithDulbecco’smodifiedEagle’s
medium DMEM/Nutrient Mixture F-12 (Gibco) containing
15% (v/v) foetal calf serum (Gibco) and seeded on 48-well
plates. Cells were left overnight to attach and all unattached cells
(including red blood cells) were washed the following day with
1! Hanks’ Balanced Salt Solution. Enzyme assays were
performed in duplicate when preadipocytes were confluent at
approximately 10 days of culture (see below). The identity of
cells were confirmed by differentiating preadipocytes from one
well of the 48-well plate intomature lipid containing adipocytes
(O90% cultured cells) using chemically defined media.11b-HSD enzyme assays in cultured orbital preadipocytes
In confluent OF preadipocytes, the culture medium was
replaced with serum-free medium 2 h before incubation.
Dehydrogenase activity (cortisol to cortisone conversion) was
assessed using 100 nMunlabelled cortisol (SigmaChemical Co)
diluted in serum-free medium and tracer amounts (1.5 nM) of
[3H]cortisol (specific activity 74.0 Ci/mmol; NEN, Boston,
MA,USA) at 37 8Cfor24 h.Conversionof cortisone to cortisol
(oxo-reductase) was analysed by incubating cells with 100 nM
cortisone and tracer amounts of [3H]cortisone (50 000 c.p.m.)
synthesised in-house (Stewart et al. 1994). After 24-h
incubation, steroids were extracted from the medium with ten
volumes of dichloromethane, separated by thin-layer chroma-
tography with chloroform:ethanol (92:8) as a mobile phase and
the fractional conversion of steroidswas calculated after scanning
analysis using a Bioscan 2000 radioimaging detector (Bioscan,
Washington, DC, USA). Following enzyme assay, cell
monolayers were lysed in 1 ml water for subsequent protein
assays. Total protein in each well was determined using a
standard protein assay reagent (Bio-Rad), and enzyme activities
were expressed as pmol/h per mg. All assays were carried out in
duplicate for each preadipocyte primary culture derived from
individual patient samples.Journal of Endocrinology (2007) 192, 279–288
I J BUJALSKA and others . 11b-HSD1 and orbital fat282Whole human adipose tissue RNA extraction and reverse
transcription
Total RNA was extracted from whole OF (nZ8), SC (nZ8)
and OM (nZ7) tissue stored in RNAlater atK20 8C using a
single-step extraction method (Tri-Reagent; Sigma-Aldrich).
RNA integrity was assessed by electrophoresis on 1% (w/v)
agarose gels, and quantity was determined spectrophotome-
trically at OD260. One microgram of total RNA was reverse
transcribed in 50 ml total volume using TaqMan Reverse
Transcription Reagents (Applied Biosystems, Warrington,
Cheshire, UK) according to the manufacturer’s guidelines.
The reaction was terminated by heating the cDNA to 95 8C
for 5 min and stored at K20 8C until required.Real-time reverse transcriptase-PCR
11b-HSD1, 11b-HSD2, H6PDH, GRa, FABP4, G3PDH
and CD68 mRNA levels were measured using real-time
PCR using an ABI 7500 system (Perkin-Elmer, Biosystems,
Warrington, UK). PCR was performed in 25 ml reactions on
96-well plates in reaction buffer containing TaqMan universal
PCR mastermix (Applied Biosystems), 3 mM Mn(Oac)2,
200 mM deoxy-NTPs, 1.25 U AmpliTaq Gold polymerase
(Perkin-Elmer), 1.25 U AmpErase UNG (Perkin-Elmer),
900 nmol primers, 100–200 nmol TaqMan probe and
25–50 ng cDNA. All reactions were multiplexed with
primers specific for 18S rRNA (provided as a pre-optimised
mix; Perkin-Elmer, Beaconsfield, Bucks, UK) as an internal
reference and were carried out in duplicate. Data were
obtained as Ct values (the cycle number at which logarithmic
PCR plots cross a calculated threshold line) and used to
determine dCt values (dCtZCt of the target gene minus Ct
of the internal reference, 18S). All target gene probes were
labelled with the fluorescent label 6-carboxyfluorescein, and
the housekeeping gene was labelled with the fluorescent label
VIC. Reactions were as follows: 50 8C for 2 min, 95 8C for
10 min, and then 40 cycles of 95 8C for 15 s and 60 8C for
1 min. All expression data are presented as fold-change when
compared with OF using the equation 2KDDCt (DDCt is the
difference between dCt values in SC or OM minus dCt in
OF). Sequences of oligonucleotide primers and probes were
as follows: (i) 11b-HSD1 antisense primer 50-AGGAAAGCT-
CATGGGAGGACTAG-30, sense primer 50-ATGGTGAA-
TATCATCATGAAAAAGATTC-30, probe 5 0-CATGCT-
CATTCTCAACCACATCACCAACA-30; (ii) GRa antisense
primer 50-GCGATGGTCTCAGAAACCAAAC-30, sense pri-
mer 5 0-GAGATTACAGAGGAAGTTATCCTCTGC-3 0,
probe 5 0-TGCAGTGAAGGTTGCTGAGGCTCTGA-3 0;
(iii) H6PDH antisense primer 50-CAGGTGTCCTAGTGCA-
CATTGAC-30, sense primer 50-GTAGCCCACTCTCTC-
GTCCAA-30, probe 50-AAGGCACGCCCTCCCAGCG-30;
(iv) G3PDH antisense primer 50-CCATCAGTTCATCGG-
CAAGAT-30, sense primer 50-TCGTCTACCCCCTTAA-
TAAGAGATATG-30, probe 50-AGGGCCATCTGAAGGCJournal of Endocrinology (2007) 192, 279–288AAACGCC-30. Primers and probes for CD68 and FABP4
were from Expression Assays Applied Biosystems.Ethics and statistical methods
The collection of human tissues for in vitro investigation was
approved by the local ethics committee. Informed consent
was obtained from all patient volunteers.
Statistical analysis was performed using the software
package SPSS for Windows Version 11.5.1 (SPSS, Inc.,
Chicago, IL, USA, 2002), Minitab Release 14.12 (Minitab
Ltd, Coventry, UK) and Prism for Windows Version 4.03c
(GraphPad Software, Inc., San Diego, CA, USA). Histo-
logical characterisation comparisons between the three fat
depots were made using a nested general linear model
regression analysis for replicated measures of data (to minimise
loss of data by averaging individual readings), followed by
integrated pairwise comparisons. Data are presented as means
and 95% confidence intervals. Enzyme assay data are
presented as means with standard errors of the separate
experiments. Real-time PCR analyses were performed with
dCt values to exclude potential bias due to averaging and
transforming data through the equation 2KDDCt to give a
fold-change in gene expression. Statistical analyses were
performed using a non-parametric Mann–Whitney test for
non-normal data, or t-test/ANOVA for normally distributed
data. P values!0.05 were accepted as statistically significant.Results
Characterisation of whole tissue adipocyte morphology
Adipocyte diameter, perimeter and area (Fig. 1A–C respect-
ively) were identified as optimal parameters differentiating
adipocyte morphology from the different depots. Mean cell
diameter, perimeter, adipocyte area and feret length defined
similar trends (OF!OM!SC; P!0.001) across the three
adipocyte depots. OF adipocytes were the smallest adipocyte
with mean cell diameter (50.7 mm, 95%CI 49.8–51.6),
shortest perimeter (149 mm, 95%CI 146.7–152.7) and smallest
area (2470 mm2, 95% CI 2382–2560). SC adipocytes were the
largest according to each of these parameters. Radius ratio, cell
roundness and margination followed similar trends to each
other across the groups but these trends were not significant
(OFOOM!SC; PZNS, data not shown), and cell count per
area of interest did not differentiate significantly between
depots. Representative haematoxylin and eosin-stained
photomicrographs detailing histomorphometric character-
isation of the three adipose depots are shown in Fig. 1D–F.Evaluation of CD68C protein and mRNA expression in human
adipose depots
The largest resident CD68C population was found in the OF
depot (median 7.6 (range 3.8–19.6) cell counts/unit area)www.endocrinology-journals.org
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Figure 1 Adipocyte morphology. Diameter of the individual adipocyte (A), perimeter cell diameter (B) and area (C), were identified as optimal
characteristics defining adipocyte morphology. Smallest adipocytes were found in the orbital fat (OF) depot (D), while SC adipocytes
were the largest cell (E). Omental (OM) adipocytes were statistically larger than OF but smaller than SC (F) (OF, nZ17; SC, nZ8; OM, nZ8;
results are expressed as mean and 95% confidence intervals; *P!0.001).
11b-HSD1 and orbital fat . I J BUJALSKA and others 283when compared with SC (median 0.7 (range 0.1–6.5) cell
counts/unit area, P!0.001) and OM (median 2.9 (range
0.6–5.2) cell counts/unit area, P!0.001; Fig. 2A). These
findings were endorsed by a similar trend in CD68 mRNA
expression for each depot (Fig. 2B (OFZ1; SCZ0.21;
P!0.05; OM 0.38!0.05 (fold-change when compared with
OF))). Representative photomicrographs showing CD68C
macrophages in each whole adipose tissue depot (OF, SC and
OM) are shown in Fig. 2C–E.Characterisation of 11b-HSD1 expression and activity in
orbital fat
Immunoreactivity was seen for 11b-HSD1 antibody in OF
sections (Fig. 3A) and around the central vein of human liver
(positive control; Fig. 3C). Minimal staining was detected
with 11b-HSD1 pre-adsorbed antibody (data not shown). No
staining was seen with 11b-HSD2 antibody in OF tissue
(Fig. 3B), whereas good staining was visualised in human
distal collecting duct epithelium in the kidney (positive
control, Fig. 3D).
Primary stromal cultures of OF preadipocytes, confirmed
11b-HSD1 oxo-reductase activity (0.69G0.5 pmol/h per
mg (meanGS.E.M.)) when incubated for 24 h with 100 nM
cortisone and minimal dehydrogenase activity
(0.11G0.08 pmol/h per mg (meanGS.E.M.); P!0.05;
Fig. 4A–C). Oxo-reductase activity was greatest in OM
preadipocytes when compared with SC (43.7G5.2 vs
17.6G3.6 pmol/mg per h (meanGS.E.M.) P!0.001) and
OF preadipocytes (OF versus SC; P!0.01; OF versus OM;
P!0.001; Fig. 4D).www.endocrinology-journals.orgComparison of 11b-HSD1 and glucocorticoid-related target gene
expression in whole adipose tissue depots
11b-HSD1 mRNAwas expressed within OF tissue, although
quantitative real-time PCR analyses across the three whole
adipose tissue depots revealed lowest levels of expression in
OF when compared with SC and OM adipose depots
(OFZ1; SCZ8.1, P!0.001; OMZ10!0.001 (fold-
change when compared with OF); Fig. 5A). Nevertheless,
these data reflect our 11b-HSD1 oxo-reductase activity data
detailed earlier.
Whole tissue analyses indicated the highest expression of
GRa mRNA in OF when compared with SC and OM
adipose tissue (Fig. 5A). Conversely, H6PDH mRNA
(NADPH provider for 11b-HSD1 oxo-reductase activity;
Fig. 5A) and markers of late adipocyte differentiation (FABP4,
G3PDH) were significantly lower in OF (Fig. 5B).Discussion
In this paper, we have described a novel reproducible
automated method for the histomorphometric analysis of
adipose tissue from differing human depots. This has been
performed in the context of gene expression profiling and has
identified important depot specific differences in adipocyte
biology and GC metabolism.
In comparison with OM and SC depots, orbital adipocytes
were significantly smaller, expressed lower levels of adipocyte
differentiation markers (FABP4 and G3PDH), but revealed a
higher CD68C cellular infiltrate. Examination of the key
players of the GC metabolic pathways, confirmed that allJournal of Endocrinology (2007) 192, 279–288
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Figure 2 Immunohistochemistry using human anti-CD68 for macrophages confirmed a large resident population in the OF depot when
compared with SC and OM (A). Results are expressed as median and full range of counts. These findings were endorsed by real-time RT-PCR
CD68 mRNA expression in each of the adipose depots (B). Results are expressed as fold-change when compared with orbital fat; dCt are shown
in table below (*P!0.05; †P!0.001). Representative sections of OF, SC and OM adipose depots with identified macrophages (Mø) are shown
in C, D and E respectively.
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published studies (Heufelder et al. 1992, Burnstine et al. 1998,
Muhlberg et al. 2000, Boullu-Ciocca et al. 2003), but
expression in the OF depot was significantly higher. In
addition, our data has defined 11b-HSD1 oxo-reductase
activity and mRNA expression in OF together with its
regulatory enzyme, H6PDH, although these were at a lower
level than that seen in SC and OM tissues.
These observations highlight the importance of adipose
tissue, depot-specific analyses. Adipose tissue is regarded as an
‘endocrine organ’ and depot specificity of gene expression
between SC and OM depots is well described (Montague
et al. 1997). Furthermore, these changes are functionally
important with differing propensities for adipocyte differen-
tiation, proliferation, apoptosis and lipid metabolism between
these depots (Vikman et al. 1995, Niesler et al. 1998). Our
data show that orbital adipose tissue is clearly distinct from
both SC and OM depots. The fundamental explanation for
these differences lies, in addition to genetic and environ-
mental factors, in the embryological origins of adipose
connective tissue. Whereas SC and OM ‘peripheral’ adipose
depots and fibroblasts are derived from mesoderm, orbitalJournal of Endocrinology (2007) 192, 279–288fibroblasts originate from neuroectoderm (Smith 2004).
Studies have shown that orbital and peripheral fibroblasts
have both distinguishing morphological phenotypic features
(Smith et al. 1995), but also at a molecular level, orbital
fibroblasts have distinct defining characteristics, including
expression of surface receptors, cellular proteins, responses to
cytokines and the ability to secrete and remodel matrix
proteins (Prabhakar et al. 2003, Ajjan & Weetman 2004,
Smith 2004). As orbital fibroblasts are neural crest in origin,
they possess considerable plasticity – under appropriate in vitro
conditions, almost 50% may be differentiated into lipid
containing adipocytes (Smith et al. 2002). Hence, it has been
proposed that the unique nature of the orbital molecular
environment accounts for its underlying susceptibility to
autoimmune diseases (Kaminski et al. 2003).
The impact of the macrophage infiltrate in orbital adipose
tissue may also be important particularly as cytokines have
potent effects upon adipocyte biology. Recent studies have
shown that chronic inflammation activates adipose tissue in
simple obesity defined by an increased accumulation of
CD68C macrophages, increased adipocyte size and increased
TNFa in patients with high BMIs (Weisberg et al. 2003,www.endocrinology-journals.org
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Figure 3 11b-HSD immunohistochemistry confirmed 11b-HSD1 expression in human orbital fat (A) and not 11b-HSD2 (B). Human
liver and kidney were used as positive control tissues for 11b-HSD1 (C) and 11b-HSD2 (D). No staining was seen in the negative
control sections (nZ5).
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Figure 4 Primary cultures of OF preadipocytes confirmed 11b-HSD1 oxo-reductase activity and
minimal dehydrogenase activity when incubated for 24 h with 100 nM cortisone and cortisol
respectively (nZ12) (A). Representative radiochromatograph traces are shown for dehydrogenase (B)
and oxo-reductase (C) activity. (D) Oxo-reductase activity was greatest in OM preadipocytes followed
by SC and OF adipocytes (*P!0.05; †P!0.01; ‡P!0.001).
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Figure 5 Whole adipose tissue real time RT-PCR analyses showed significantly higher expression of 11b-HSD1 and H6PDH mRNA in SC
and OM when compared with OF. Conversely, highest expression of GRa mRNA in OF when compared with SC and OM is seen (A).
FABP4, G3PDH mRNA expression (markers of late adipocyte differentiation) were significantly lower in OF (B). Results are expressed as
fold-change when compared with orbital fat; dCt are shown in tables below (*P!0.05; †P!0.001).
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Pietila¨inen et al. 2006). There is considerable heterogeneity
in monocyte-derived lineages (e.g. macrophages) and the
different monocyte subsets reflect the developmental stages
with distinct physiological roles, such as recruitment into
inflammatory lesions or entry to normal tissues (Gordon &
Taylor 2005). It is thought that with the expansion of adipose
tissue during weight gain, induction of a range of signalling
pathways activates the adipose vascular fraction allowing
monocytes to extravasate through the endothelial cell layer
into the adipose tissue where they differentiate into
macrophages localising predominantly around dead
adipocytes (Neels & Olefsky 2006). Crosstalk between
adipocytes, macrophages and endothelial cells aggravates
the inflammatory state, resulting in increased secretion of
pro-inflammatory cytokines/chemokines, adipokines and
angiogenic factors. Furthermore, the interaction of cytokines
and GC metabolism may be an additional contributing factor.
TNFa, IL-6 and IL-1b are potent inducers of 11b-HSD1
expression and activity in adipose tissue (Tomlinson et al.
2001). Macrophage-derived cytokine production in vivo may
serve to augment cortisol generation through induction of
11b-HSD1. TNFa specifically, in addition to modulating
11b-HSD1 activity, inhibits adipocyte differentiation,
proliferation and promotes apoptosis and de-differentiation
(Petruschke & Hauner 1993, Prins et al. 1997). This process
may be of considerable relevance to the orbital fat
microenvironment. The orbital fat samples analysed in this
study were all from healthy controls undergoing elective
orbital or lid surgery for non-inflammatory disease states, and
despite this, normal OF harboured a large CD68C populationJournal of Endocrinology (2007) 192, 279–288and adipocytes were less differentiated when compared with
SC and OM. These data reflect an orbital molecular
environment that has an increased potential and plasticity
that is vital to combat inflammatory, immune-mediated or
infective insult.
The role of GCs in the regulation of adipocyte biology is
exemplified by patients with Cushing’s syndrome who
develop florid, but reversible central obesity. GCs are essential
for adipocyte differentiation (Hauner et al. 1987), inhibit
omental preadipocyte proliferation (Tomlinson et al. 2002),
but interestingly, promote proliferation in the SC depot
(Bader et al. 2002). 11b-HSD1 overexpression in adipose
tissues in rodent models induces obesity and the metabolic
syndrome (Masuzaki et al. 2001, 2003) and selective
11b-HSD1 inhibitors have been suggested as a novel
therapeutic strategy (Alberts et al. 2002, 2003, Hermanows-
ki-Vosatka et al. 2005). The identification of 11b-HSD1 in
human orbital adipose tissue is an important finding and raises
the possibility that the local generation of GC within this
depot may be functionally important. Although levels were
lower than those observed in SC and OM depots, the
increased expression of GRa is likely to compensate for this.
Low levels of oxo-reductase activity have been documented
in other tissue depots, notably bone (Cooper et al. 2002). In
this tissue, low basal levels are believed to be physiologically
significant, as induction of oxo-reduction activity increasing
GC bioavailability is seen when osteoblasts are challenged
with pro-inflammatory cytokines (Cooper et al. 2001).
Critically, unlike the SC and OM depots, the orbital fat
depot lies within a confined space surrounding tissues
susceptible to compression. Therefore, rapid expansion,www.endocrinology-journals.org
11b-HSD1 and orbital fat . I J BUJALSKA and others 287perhaps as a consequence of enhanced GC autocrine
generation through 11b-HSD1, may have important sight-
threatening clinical implications. The possibility of dysregula-
tion of 11b-HSD1 in disease states (particularly those with
underlying inflammatory and immune-mediated aetiologies)
requires further investigation, and a detailed characterisation
of expression and functional importance in these conditions is
now warranted.
To conclude, orbital adipose tissue is a biologically distinct
adipose tissue depot. Adipocytes are smaller and less
differentiated than SC and OM. The identification of 11b-
HSD1 and H6PDH expression and activity within the depot,
together with an abundant GRa and a large CD68C
population define a microenvironment that has the potential
to respond to sight-threatening orbital inflammatory disease.
Our data raise the exciting possibility that the autocrine
generation of cortisol may be functionally important in
regulating orbital adipocyte biology and that this may be
amenable to therapeutic modulation.Acknowledgements
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